Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 17, 2006Bioconjugate Chemistry

Evaluation of RGD-Targeted Albumin Carriers for Specific Delivery of Auristatin E to Tumor Blood Vessels

View Full Paper
Ask AI
Bookmark
Share

Authors

KTKai TemmingDMDamon L. MeyerUniversity Medical Center GroningenRZRoger F. ZabinskiSeagen (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Temming et al. (2006) studied this question.

synapsesocial.com/papers/6a9cfe2d5c8542d13d736fe5https://doi.org/10.1021/bc060087z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Delivery of the p38 MAPkinase Inhibitor SB202190 to Angiogenic Endothelial Cells: Development of Novel RGD-Equipped and PEGylated Drug−Albumin Conjugates Using Platinum(II)-Based Drug Linker Technology2006 · 46 citations
  2. 2Rational Design of RGD–Albumin Conjugates for Targeted Delivery of the VEGF‐R Kinase Inhibitor PTK787 to Angiogenic Endothelium2006 · 32 citations
  3. 3Tumor Targeting by Surface-Modified Protein Microspheres2006 · 113 citations